课题基金 / 基金详情

FACSAria II Cell Sorter

FACSAria II Cell Sorter
FACSAria II 细胞分选仪
批准号:
7791758
负责人:
ZBIGNIEW DARZYNKIEWICZ
金额:
$50.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-02-20 至 2011-02-19

项目摘要

项目成果

ZBIGNIEW DARZYNKIEWICZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The broad, long term objective of this application is to provide investigators at New York Medical College with a FACSAria II high-speed cell sorter to advance studies in important research areas including diabetes, Lyme disease, renal disease, pulmonary hypertension, coronary vessel and heart disease, and DNA damage caused by genotoxic agents. There are no instruments available in the surrounding area that can provide sterile, high- speed isolation of important cell types or multi-parameter analysis of complex cell populations. The many important research projects currently supported by the National Institutes of Health would benefit tremendously by having access to an instrument that could analyze highly complex populations and identify relatively rare cells that could then be purified and used for further experimentation. The current, outdated Coulter Epics ESP cell sorter cannot provide the speed nor accuracy in sorting required of the various investigators. The new instrument would provide both the biosafety necessary for the operator to work with cells containing infectious particles as well as provide high yields of cells in a sterile environment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EXPRESSION OF CELL CYCLE DEPENDENT CYCLINS MEASURED BY FLOW CYTOMETRY
MONITOR UPTAKE, RETENTION, SUBCELL LOCALIZATION & LIFETIME OF FLUORESCENT DRUGS
EXPRESSION OF CELL CYCLE DEPENDENT CYCLINS MEASURED BY FLOW CYTOMETRY
MONITOR UPTAKE, RETENTION, SUBCELL LOCALIZATION & LIFETIME OF FLUORESCENT DRUGS
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: